• Exchange: NASDAQ CM
  • Sector: Health Care
  • Industry: Health Care Facilities/Srvcs
  • Sub-Industry: Health Care Services

NBS:US

6.2100 USD 0.1100 1.80%

As of 12:05:30 ET on 07/30/2014.

Snapshot for NeoStem Inc (NBS)

Open: 6.2000 Day's Range: 6.1500 - 6.2400 Volume: 87,044
Previous Close: 6.1000 52wk Range: 4.5600 - 9.8900 1-Yr Rtn: -13.46%

Stock Chart for NBS

No chart data available.
  • NBS:US 6.2100
  • 1D
  • 1M
  • 1Y
6.1000
Interactive NBS Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for NBS

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -1.8700
Est. EPS (USD) (12/2014) -1.4000
Est. PEG Ratio -
Market Cap (M USD) 210.31
Shares Outstanding (M) 33.92
30 Day Average Volume 318,963
Price/Book (mrq) 2.9747
Price/Sale (ttm) 8.6572
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 08/08/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for NBS

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for NBS

NeoStem, Inc. develops and manufactures cell therapies. The Company through its subsidiaries offers contract manufacturing services and is developing a cell therapy for the treatment of cardiovascular disease.

Robin L SmithChairman/CEOAndrew L PecoraChief Visionary Officer
Douglas W LosordoChief Medical OfficerStephen W PotterExec Vice President
More Company Profile & Key Executives for NBS

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil